Microdermis iodine-based antiseptic adopted by US Army in fight against Ebola
Published: Friday, 05 December 2014
The company’s iodine-based product, Provodine, together with its unique topical drug delivery system, has been tested by the US Army and shown to kill 99% of the virus. Adoption by the US Army lends backing to the product, and Mircrodermis has ramped up production, anticipating an increase in demand.
Privately-owned life sciences company Microdermis Corp. has
launched a new iodine-based antiseptic product, which will be
deployed by the US Army to help fight the spread of Ebola in West
The antiseptic skin product, Provodine, is applied as a
final molecular barrier for healthcare workers and emergency